EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Control of CCR5 Cell-Surface Targeting by the PRAF2 Gatekeeper

Elisa Da Silva, Mark G H Scott, Hervé Enslen iD, Stefano Marullo iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242417438 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Elisa Da Silva und 3 weiteren Autor:innen. Beteiligte Einrichtung: CNRS, INSERM, Institut Cochin, Université Paris Cité, F-75014 Paris, France. Hauptthemen laut MEDLINE: Carrier Proteins, Membrane Proteins, Receptors, CCR5. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Inserm, CNRS and Université Paris Cité.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The cell-surface targeting of neo-synthesized G protein-coupled receptors (GPCRs) involves the recruitment of receptors into COPII vesicles budding at endoplasmic reticulum exit sites (ERESs). This process is regulated for some GPCRs by escort proteins, which facilitate their export, or by gatekeepers that retain the receptors in the ER. PRAF2, an ER-resident four trans- membrane domain protein with cytoplasmic extremities, operates as a gatekeeper for the GB1 protomer of the heterodimeric GABAB receptor, interacting with a tandem di-leucine/RXR retention motif in the carboxyterminal tail of GB1. PRAF2 was also reported to interact in a two-hybrid screen with a peptide corresponding to the carboxyterminal tail of the chemokine receptor CCR5 despite the absence of RXR motifs in its sequence. Using a bioluminescence resonance energy transfer (BRET)-based subcellular localization system, we found that PRAF2 inhibits, in a concentration-dependent manner, the plasma membrane export of CCR5. BRET-based proximity assays and Co-IP experiments demonstrated that PRAF2/CCR5 interaction does not require the presence of a receptor carboxyterminal tail and involves instead the transmembrane domains of both proteins. The mutation of the potential di-leucine/RXR motif contained in the third intracellular loop of CCR5 does not affect PRAF2-mediated retention. It instead impairs the cell-surface export of CCR5 by inhibiting CCR5’s interaction with its private escort protein, CD4. PRAF2 and CD4 thus display opposite roles on the cell-surface export of CCR5, with PRAF2 inhibiting and CD4 promoting this process, likely operating at the level of CCR5 recruitment into COPII vesicles, which leave the ER.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carrier ProteinsMembrane ProteinsReceptors, CCR5Cell MembraneLeucineProtein TransportReceptors, G-Protein-CoupledReceptors, GABA-BHumans

Stichwörter der Autor:innen

BRETERESG protein-coupled receptorbiosensorcell traffickingendoplasmic reticulumescort proteingatekeeper

Substanzen

Carrier ProteinsLeucineMembrane ProteinsReceptors, CCR5Receptors, G-Protein-CoupledReceptors, GABA-BCCR5 protein, humanPRAF2 protein, human

Autor:innen und Institutionen

  • CNRS, INSERM, Institut Cochin, Université Paris Cité, F-75014 Paris, France.

ORCID-Profile: Hervé Enslen, Stefano Marullo

Förderung

  • Inserm, CNRS and Université Paris Cité

Zitieren

APA

Da Silva, E., Scott, M. G. H., Enslen, H., & Marullo, S. (2023). Control of CCR5 Cell-Surface Targeting by the PRAF2 Gatekeeper. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242417438

Vancouver

Da Silva E, Scott MGH, Enslen H, Marullo S. Control of CCR5 Cell-Surface Targeting by the PRAF2 Gatekeeper. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242417438

BibTeX
@article{DaSilva2023,
  author = {Da Silva, Elisa and Scott, Mark G H and Enslen, Hervé and Marullo, Stefano},
  title = {Control of CCR5 Cell-Surface Targeting by the PRAF2 Gatekeeper},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242417438}
}
Kostenlos starten →